NetworkNewsBreaks

WednesdayFeb 19, 2020 2:09 pm

NetworkNewsBreaks – Selecta Biosciences Inc. (NASDAQ: SELB) Featured in Mizuho Securities Research Report

Selecta Biosciences (NASDAQ: SELB) was featured in a recent U.S. Equity Research Report published by Mizuho Securities USA LLC. The report reads, “We are increasing our 12-month price target on Selecta from $4 to $7, following the release of encouraging interim data in the COMPARE trial in December, 2019 and the removal of the financing overhang. We are increasing our probability of success for SEL-212, due to the favorable COMPARE data to date. Longer-term, we remain positive on the company's ImmTOR platform, which could allow for the re-dosing of gene therapy. The company's collaboration agreement with AskBio, particularly the licensing…

Continue Reading

WednesdayFeb 19, 2020 1:03 pm

NetworkNewsBreaks – InnerScope Hearing Technologies Inc. (OTC: INND) Engages DigiMax Global Solutions Inc. (CSE: DIGI) to Assist in Equity Capital Raising Efforts

InnerScope Hearing Technologies (OTC: INND) today announced its engagement of DigiMax Global Solutions (CSE: DIGI) to raise $15 million in private placement offerings for its current growth, and to retire most, if not all, of its remaining convertible debt. Further, InnerScope has been in discussions with its noteholders for negotiated payoff terms for its remaining convertible debt and expects shareholder value to quickly increase at time of payoff. The Private Placement will additionally finance InnerScope's plans for a national rollout of 1000+ Point of Sale Hearing Screening Retail Kiosk ("Hearing Kiosks") locations as well as fulfilling its current orders of…

Continue Reading

WednesdayFeb 19, 2020 12:53 pm

NetworkNewsBreaks – US Nuclear Corp. (UCLE) Enters Stock Purchase Agreement with Grapheton Inc. to Join Brain-Machine Interface Revolution

US Nuclear (OTC: UCLE) recently entered into a stock purchase agreement with start-up Grapheton Inc. to acquire a 40% stake in the company. According to the update, Grapheton, similar to Elon Musk’s “Neuralink,” is developing and manufacturing an advanced new generation of wearable and implantable brain-machine interface devices. Grapheton already has several pivotal and patented advantages in the field with products already in use at various research centers. The company’s long-term goal is dedicated specifically to treating injuries and disease such as spinal injuries, pain reduction, Parkinson’s Disease, epilepsy, stroke, and possibly Alzheimer’s. To view the full press release, visit…

Continue Reading

WednesdayFeb 19, 2020 11:52 am

NetworkNewsBreaks – OrgHarvest Inc. (ORGH) Appoints J. Larry Cantrell as President and Chief Executive Officer

OrgHarvest (OTC: ORGH), a newly launched and complete seed-to-consumer hemp company, today announced that J. Larry Cantrell has succeeded Frank Celecia as its president and chief executive officer, based on the January 28, 2020, Stock Purchase Agreement, which caused a change of control of the company. Cantrell brings over 30 years of experience in the development, branding, manufacturing and distribution of nutritional strategies, having led and directed the development and launch of more than 100 products into the global marketplace. A long-time advocate of all-natural nutritional products, Cantrell, earlier in his career, was recognized by an industry publication as “one…

Continue Reading

WednesdayFeb 19, 2020 10:46 am

NetworkNewsBreaks – Treasure & Shipwreck Recovery, Inc. (BLIS) Completes Purchase of Multimedia App and Inventory for its Treasure Gaming Launch

Treasure & Shipwreck Recovery (“TSR”), currently trading as Beliss Corp. (OTC: BLIS), through its subsidiary TSR Media Group, today announced its purchase of a 9-year-old multiplatform mobile and desktop app developer site with a long and successful track record, including multiple Amazon.com “Best Sellers” in the lifestyle category. With the purchase, TSR now has the expertise, software development capability and an existing revenue-producing arm to complete one part of its threefold business cycle that consists of treasure recovery as its main mission, as well as providing a huge multiplatform gaming experience and developing a reality television and multimedia pilot and…

Continue Reading

WednesdayFeb 19, 2020 9:55 am

NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Secures Cannabis Research License from Health Canada

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, this morning announced that it has received a research license from Health Canada. The license is valid for five years and enables TGODF to cut the costs and quicken the pace of the development of new products by removing its need to rely on third parties. Looking forward, the company plans to leverage the license to carry out the development of additional premium cannabis 2.0 products, which are anticipated to launch later this year. “As consumers become increasingly aware that not all cannabis products…

Continue Reading

WednesdayFeb 19, 2020 9:45 am

NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Closes Firm Commitment Common Stock Offering

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, on Tuesday announced the closing of its underwritten public offering of 806,452 shares of common stock at a price to the public of $6.50 each. The company granted the underwriters a 45-day option to obtain up to an additional 120,967 shares of common stock to cover any overallotments. Before the deduction of underwriting discounts and offering expenses, the company secured gross proceeds of $5.24 million from the offering, which it plans to utilize…

Continue Reading

TuesdayFeb 18, 2020 2:11 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Founder & CEO Discusses Revolutionary BIGtoken Platform in Exclusive Interview

SRAX (NASDAQ: SRAX) founder and CEO Christopher Miglino recently discussed how the company’s proprietary BIGtoken platform has transformed consumer data collection during an exclusive interview at the LD Micro Main Event 2019. An article discussing the company reads, “With 16.4 million users worldwide, and three to five thousand new users joining each day, BIGtoken may be the most valuable opted-in data set in the world, said Miglino during the interview with SNN’s Robert Crafton (http://nnw.fm/vH7m8). Those numbers prove that consumers are looking for ways to receive compensation from marketers for using their data, said Miglino. Users worldwide can sign into the…

Continue Reading

TuesdayFeb 18, 2020 2:06 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Strikes Licensing Deal with Cannadips CBD

British Columbia-based Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently entered a definitive agreement to provide its patented DehydraTECH(TM) technology to Cannadips CBD. An article discussing the company reads, “The agreement announced recently provides Cannadips CBD with exclusive access rights to Lexaria’s technology for the U.S. market for 10 years, granting the ‘Original Smokeless CBD Dip Brand’ Lexaria’s fast-acting, high-absorption technology with options to expand the license to Europe, Mexico, and Canada and to renew the license for an additional five years (http://nnw.fm/6So1j). . . . ‘This combination of superior science from Lexaria and a unique and strong branded proposition that Cannadips…

Continue Reading

TuesdayFeb 18, 2020 12:11 pm

NetworkNewsBreaks – SiTime Corporation (NASDAQ: SITM) Featured in ROTH Equity Research Report

SiTime (NASDAQ: SITM) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “We believe SITM represents a differentiated investment opportunity in growth of timing semiconductor devices across a diversified set of end market opportunities. We are encouraged by strong upside in the company’s first quarter as a public company and believe SITM is well funded to execute on its growth and margin expansion plan. We raise our price target from $25 to $40 and maintain our Buy rating.” To request access to the full report, visit http://nnw.fm/DXCr3 About SiTime SiTime Corporation is…

Continue Reading